|
122
|
316
|
8bplA |
Aspartate transcarbamoylase mutant (n2045c, r2238c) from chaetomium thermophilum cad-like bound to carbamoyl phosphate |
|
123
|
362
|
8gvzA |
Crystal structure of the human dihydroorotase domain in complex with the anticancer drug 5-fluorouracil |
|
127
|
362
|
8gw0A |
Crystal structure of the human dihydroorotase domain in complex with malic acid |
|
116
|
362
|
8pbtA |
Mutant k1482m of the dihydroorotase domain of human cad protein bound to the substrate dihydroorotate |
|
117
|
362
|
8pbeA |
Mutant k1556t of the dihydroorotase domain of human cad protein bound to the substrate carbamoyl aspartate |
|
115
|
363
|
8pbrA |
Mutant r1475q of the dihydroorotase domain of human cad protein in apo form |
|
107
|
362
|
8pbsA |
Mutant k1482m of the dihydroorotase domain of human cad protein in apo form |
|
118
|
362
|
8pbnA |
Mutant r1789q of the dihydroorotase domain of human cad protein bound to the inhibitor fluoorotate |
|
116
|
362
|
8pbkA |
Mutant r1722w of the dihydroorotase domain of human cad protein bound to the inhibitor fluoorotate |
|
115
|
362
|
8pbjA |
Mutant r1722w of the dihydroorotase domain of human cad protein bound to the substrate carbamoyl aspartate |
|
119
|
362
|
8pbgA |
Mutant k1556t of the dihydroorotase domain of human cad protein bound to the inhibitor fluoroorotate |
|
115
|
354
|
8pbqA |
Mutant r1810q of the dihydroorotase domain of human cad protein bound to the substrates |
|
116
|
362
|
8pbuA |
Mutant k1482m of the dihydroorotase domain of human cad protein bound to the inhibitor fluoorotate |
|
117
|
362
|
8pbhA |
Mutant r1617q of the dihydroorotase domain of human cad protein bound to the substrate carbamoyl aspartate |
|
118
|
362
|
8pbmA |
Mutant r1789q of the dihydroorotase domain of human cad protein bound to the substrate dihydroorotate |
|
116
|
362
|
8pbpA |
Mutant r1785c of the dihydroorotase domain of human cad protein bound to the substrate carbamoyl aspartate |
|
119
|
362
|
8pbiA |
Mutant r1617q of the dihydroorotase domain of human cad protein bound to the inhibitor fluoroorotate |
|
112
|
315
|
8bpsA |
Aspartate transcarbamoylase mutant (n2045c, r2238c) from chaetomium thermophilum cad-like in apo form |
|
108
|
335
|
7zidA |
Crystal structure of truncated aspartate transcarbamoylase from plasmodium falciparum in complex with bda-14 |
|
109
|
345
|
7zczA |
Crystal structure of truncated aspartate transcarbamoylase from plasmodium falciparum with bound inhibitor 1-(4-chlorophenyl)methanamine |
|
106
|
336
|
7zstA |
Crystal structure of truncated aspartate transcarbamoylase from plasmodium falciparum in complex with fla-01 |
|
110
|
345
|
7zeaA |
Crystal structure of truncated aspartate transcarbamoylase from plasmodium falciparum with bound inhibitor o-benzylhydroxylamine |
|
109
|
345
|
7zhiA |
Crystal structure of truncated aspartate transcarbamoylase from plasmodium falciparum with bound inhibitor indole |
|
110
|
345
|
7zp2A |
Crystal structure of truncated aspartate transcarbamoylase from plasmodium falciparum in complex with bda-04 |
|
115
|
345
|
7zgsA |
Crystal structure of truncated aspartate transcarbamoylase from plasmodium falciparum with bound inhibitor 2-phenylethan-1-amine |
|
106
|
309
|
6kjbA |
Wild-type apo-form e. coli atcase holoenzyme with an unusual open conformation of r167 |
|
121
|
293
|
6pnzA |
The structure of the aspartate transcarbamoylase trimer from staphylococcus aureus complexed with pala at 2.27 resolution. |
|
121
|
362
|
6hfuA |
Human dihydroorotase mutant f1563y co-crystallized with carbamoyl aspartate at ph 7.5 |
|
121
|
362
|
6hfrA |
Human dihydroorotase mutant f1563y co-crystallized with carbamoyl aspartate at ph 7.0 |
|
121
|
362
|
6hfeA |
Human dihydroorotase mutant f1563t apo structure |
|
120
|
362
|
6hfsA |
Human dihydroorotase mutant f1563y co-crystallized with carbamoyl aspartate at ph 6.5 |
|
122
|
362
|
6hfqA |
Human dihydroorotase mutant f1563t co-crystallized with carbamoyl aspartate at ph 7.5 |
|
122
|
362
|
6hfnA |
Human dihydroorotase mutant f1563l co-crystallized with carbamoyl aspartate at ph 7.5 |
|
119
|
362
|
6hflA |
Human dihydroorotase mutant f1563l co-crystallized with carbamoyl aspartate at ph 7.0 |
|
122
|
366
|
6hg3A |
Hybrid dihydroorotase domain of human cad with e. coli flexible loop, bound to dihydroorotate |
|
122
|
362
|
6hfpA |
Human dihydroorotase mutant f1563t co-crystallized with carbamoyl aspartate at ph 7.0 |
|
119
|
362
|
6hffA |
Human dihydroorotase mutant f1563y apo structure |
|
120
|
364
|
6hg2A |
Hybrid dihydroorotase domain of human cad with e. coli flexible loop, bound to fluoroorotate |
|
122
|
345
|
5ilnA |
Crystal structure of aspartate transcarbamoylase from plasmodium falciparum (pfatc) with bound citrate |
|
121
|
362
|
6hfjA |
Human dihydroorotase mutant f1563a co-crystallized with carbamoyl aspartate at ph 7.5 |
|
120
|
362
|
6hfdA |
Human dihydroorotase mutant f1563l apo structure |
|
121
|
363
|
6hfhA |
Human dihydroorotase mutant f1563a co-crystallized with carbamoyl aspartate at ph 7.0 |
|
120
|
362
|
6hfiA |
Human dihydroorotase mutant f1563a apo structure |
|
112
|
371
|
6hg1A |
Hybrid dihydroorotase domain of human cad with e. coli flexible loop in apo state |
|
120
|
362
|
6hfkA |
Human dihydroorotase mutant f1563l co-crystallized with carbamoyl aspartate at ph 6.5 |
|
110
|
363
|
5ynzA |
Crystal structure of the dihydroorotase domain (k1556a) of human cad |
|
119
|
310
|
8at1A |
Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and ctp or atp at 2.8-angstroms resolution and neutral p*h |
|
107
|
310
|
8atcA |
Complex of n-phosphonacetyl-l-aspartate with aspartate carbamoyltransferase. x-ray refinement, analysis of conformational changes and catalytic and allosteric mechanisms |
|
83
|
310
|
9atcA |
Atcase y165f mutant |
|
120
|
310
|
7at1A |
Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and ctp or atp at 2.8-angstroms resolution and neutral p*h |
